News & numbers Global spending on Covid-19
The outlook for global medicine spending shifted considerably during the Covid-19 pandemic but is expected to be largely similar to the pre-Covid outlook – excluding the spending for vaccines and therapeutics. The latest report on the global use of medicines from IQVIA Institute for Human Data Science gives insight into how spending has changed during the pandemic, and the organisation’s prediction for spending over the next seven years.
Changes in the historical and projected global medicine spending model due to Covid-19, 2019–2027 51 53 117 3 1,278 2019 1,312 2020 1,450 2021 1,482 2022 1,557 2023 92 75 60 1,651 1,742 1,828 1,917 50
Covid-19 vaccination spending expected to exceed prior estimates
2024 Incremental spend for Covid-19 vaccines and therapeutics 2025 Pre-Current outlook excluding Covid-19 vaccines Cumulative difference 497 104 3 -19 2019 -19 -75 -72 2020 -62 2021 16 158 57 -87 2022 211 53 124 -106 2023 256 181 76 -99 2024
Cumulative difference in non-Covid-19 spending from pre-Covid-19 levels Cumulative Covid-19 therapeutics
The amount global spending is expected to reach by 2027 on Covid-19, proving the illness is still a major driver and far exceeds pre-pandemic levels from 2020.
$497bn 91 -76 2025 103 -43 2026 Total cumulative difference from pre-Covid-19 levels
The expected reduction from pre-pandemic levels on outlooks for non-Covid spending.
$4bn $380bn $120bn
The total spend expected to result from the use of novel therapeutics.
The estimated total spend expected to result from the rollout of vaccines and booster shots.
Source: IQVIA Institute for Human Data Science report: Global Use of Medicines 2023, Outlook to 2027 World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net 9 112 -4 2027 Cumulative Covid-19 vaccine spending 120
$20 $15 $10 $5 0
10 8 6 4 2 0
247 297 323 338 407 380 2026 Pre-Covid-19 outlook 2027
120 100 80 60 40 20 0
Updated 7 year total of base case = $380bn (315–425)
Previous 6 year total of base case = $251bn (185–295)
2021 2022 2023 2024 2025 2026 2027
Cost per dose scenarios, $bn 2021 2022 2023 2024 2025 2026 2027
Standard doses scenarios, $bn 2021 2022 2023 2024 2025 2026 2027
Previous scenario range Updated base case scenario Previous base case scenario
SergeyBitos/
www.shutterstock.com US$bn US$bn
Constant US$, billion
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49
